p53 Mutations and expression in breast carcinoma in situ

American Journal of Pathology

Volumn 156, Issue 1, 2000, Pages 183-191

  Lukas, Jason ^a   Niu, Ning ^a   Press, Michael F ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER INVASION; CONTROLLED STUDY; DNA SEQUENCE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SOLID TUMOR; TUMOR SUPPRESSOR GENE;

EID: 0033903546     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64718-9     Document Type: Article

References (41)

1. Biomarkers in early breast neoplasia
2. Benign breast changes and risk for subsequent breast cancer
3. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsies
4. Immunohistochemical studies of early breast cancer evolution
5. p21(WAF1) immunohistochemical expression in breast carcinoma: Correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alteration and relapse-free survival
6. Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease
7. Ductal carcinoma in situ: Assessment of necrosis and nuclear morphology and their association with biological markers
8. p53 Protein expression in ductal carcinoma in situ (DCIS) of the breast
9. bcl-2 Expression in the spectrum of preinvasive breast lesions
10. Ductal carcinoma in situ: Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2
11. Immunohistochemical evaluation of multiple biological markers in ductal carcinoma in situ of the breast
12. p53 Protein expression in human breast carcinoma: Relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor
13. p53 Protein expression in mammary ductal carcinoma in situ: Relationship to immunohistochemical expression of estrogen receptor and c-erbB2-protein
14. Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers
15. Expression of p53 protein in infiltrating and in situ breast carcinomas
16. Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification: A study of 127 cases. Correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity
17. p53 Mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade
18. TP53 alteration in atypical ductal hyperplasia, and ductal carcinoma in situ of the breast
19. Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ
20. p53 Mutations are confined to the comedo type ductal carcinoma in situ of the breast
21. Maintenance of p53 alterations throughout breast cancer progression
22. Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade
23. WAF1/Cip1 gene polymorphism, and expression in carcinomas of the breast, ovary, and endometrium
24. p53 Mutations and expression in ovarian cancers: Correlation with overall survival
25. HER-2/neu oncogene expression and DNA ploidy analysis in breast cancer
26. Clinical implications of the p53 tumor suppressor gene
27. p53 Mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasia
28. Role of a p53 polymorphism in the development of human papilloma-virus associated cancer
29. No evidence of p53 allele-specific predisposition in human papillomavirus-associated cervical cancer
30. Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies
31. Polymorphism at codon 213 within the p53 gene
32. Frequent p53 gene mutations and novel alleles in familial breast cancer
33. Mutations in the fibroblast growth factor receptor 2 gene cause crouzon syndrome
34. How loops, β sheets and α helices help us to understand p53
35. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations
36. High-resolution structure of the oligomerization domain of p53 by multidimensional NMR
37. Refined solution structure of the oligomerization domain of the tumor suppressor p53
38. Cytoplasmic regulation of mRNA function: The importance of the 3' untranslated region
39. Identification of two KH domain proteins in the α-globin mRNP stability complex
40. Detection and characterization of a 3' untranslated region ribonucleoprotein complex associated with human α-globin mRNA stability